Patient P-02292
Synthetic patientMETA-24 · Day 104 · 25–34 · F · baseline S11Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
12%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S11
- Day 43 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 43.
Primary contributors, last 14 days
- GI instability-14
- Inflammatory activity-5
- Nutritional resilience+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable82 min
stable · +1.6 vs previous 14 d
Sleep duration
Wearable6.5 h
stable · -0.1 vs previous 14 d
Energy level
Daily log5.4/10
stable · +0.0 vs previous 14 d
Steps
Wearable8,294
improving · +350 vs previous 14 d
GI burden
Companion14.8/100
worsening · +1.8 vs previous 14 d
Adherence
Companion82.3 %
stable · +1.1 vs previous 14 d
Sleep quality
Wearable43.6/100
stable · +0.5 vs previous 14 d
Glucose, CGM daily mean
CGM134 mg/dL
stable · +2.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 68 from the failing basin, 47 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +5
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -3.2 next day
Main detractors to watch
- IL6 high-expression varianthidden · steering -7.3
- Ultra-processed foodperturbation · steering -6.9
- Alcohol on dosing daysperturbation · steering -1.8
- Ultra-processed fooddetractor · GI +4.1 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Ultra-processed food+4.1detractor · 95%
- Protein-3.2supporter · 95%
- Insoluble fibre-1.3no signal · 38%
- Alcohol+0.8no signal · 22%
- Histamine load-0.4no signal · 15%
- Dietary fat load-0.2no signal · 15%
- Caffeine-0.2no signal · 15%
- Simple carbohydrates-0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓25
- DNAIL6 -174 variant raises baseline inflammatory tone
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.3 · butyrate capacity 61/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 50 ms
- Sleep
- 6.1 h
- Steps
- 7,120
- Resting HR
- 72 bpm
Daily log: GI score 15, nutritional resilience 68, adherence 82.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02016 | 52% | S20 | DT-01 | improved | 27 |
| P-02331 | 42% | S14 | BR-03 | improved | 34 |
| P-02564 | 41% | S15 | BR-03 | improved | 32 |
| P-02391 | 34% | S19 | HY-01 | improved | 53 |
| P-02479 | 34% | S13 | DT-01 | improved | 48 |
| P-02484 | 34% | S15 | GI-04 | improved | 49 |
| P-02494 | 34% | S09 | GI-04 | improved | 47 |
| P-02031 | 33% | S12 | AD-05 | improved | 47 |
| P-02339 | 33% | S03 | DT-01 | improved | 50 |
| P-02455 | 33% | S09 | DT-01 | improved | 50 |
| P-02033 | 32% | S06 | GI-04 | improved | 51 |
| P-02223 | 32% | S20 | HY-01 | improved | 49 |